Clinical trial

Expanded Access to NanoPac

NCT03756311

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Study timeline

Registry last updated2026-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced Pancreatic Carcinomaunresolved

Prostate Cancerverified · MONDO: prostate cancer

Lung Cancerverified · MONDO: lung cancer

Interventions

NanoPac (sterile nanoparticulate paclitaxel) Powder for SuspensionDRUG

Sponsors & collaborators

NanOlogy, LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03756311 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.